{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:28:02Z","timestamp":1788424082731,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["IHS-1507-31640"],"award-info":[{"award-number":["IHS-1507-31640"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["IHS-1507-31640"],"award-info":[{"award-number":["IHS-1507-31640"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["IHS-1507-31640"],"award-info":[{"award-number":["IHS-1507-31640"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["IHS-1507-31640"],"award-info":[{"award-number":["IHS-1507-31640"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["IHS-1507-31640"],"award-info":[{"award-number":["IHS-1507-31640"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["IHS-1507-31640"],"award-info":[{"award-number":["IHS-1507-31640"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["IHS-1507-31640"],"award-info":[{"award-number":["IHS-1507-31640"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012464","name":"Kaleida Health Foundation","doi-asserted-by":"publisher","award":["Troup Fund"],"award-info":[{"award-number":["Troup Fund"]}],"id":[{"id":"10.13039\/100012464","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012464","name":"Kaleida Health Foundation","doi-asserted-by":"publisher","award":["Troup Fund"],"award-info":[{"award-number":["Troup Fund"]}],"id":[{"id":"10.13039\/100012464","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012464","name":"Kaleida Health Foundation","doi-asserted-by":"publisher","award":["Troup Fund"],"award-info":[{"award-number":["Troup Fund"]}],"id":[{"id":"10.13039\/100012464","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Res Involv Engagem"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>People who use drugs (PWUD) have difficulty participating in clinical research. We evaluated approaches to engage PWUD in clinical research, using facilitated telemedicine for hepatitis C virus (HCV) care as an example.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We analyzed stakeholder interview transcripts and study-related data (i.e., progress reports, meeting minutes) from interrelated studies to understand engagement experiences at the patient, site, and organizational levels. Stakeholders include patient-participants, opioid treatment program (OTP) staff and administrators, and research team members involved in HCV management through facilitated telemedicine integrated into OTPs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Three themes emerged. Initially, the research team sought understanding of the unique culture and community of each OTP (Theme 1). The team built trusting relationships through education, communication, and feedback (Theme 2). Finally, the research team enhanced collaborative care and incorporated the patients\u2019 voice to improve health outcomes (Theme 3). Patient-participants and OTP staff endorsed the integrated HCV care approach. Engagement practices are summarized as the CREATE framework (C\u2009=\u2009culture, R\u2009=\u2009respect, E\u2009=\u2009educate, A\u2009=\u2009advantage, T\u2009=\u2009trust, E\u2009=\u2009endorse).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>PWUD engagement in clinical research is maximized by building trusting relationships with open communication channels. Understanding the community, demonstrating respect, and augmenting knowledge are foundational for engaging PWUD in clinical research. These practices are transferable to engagement of PWUD in clinical research broadly.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40900-023-00474-x","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T13:02:33Z","timestamp":1690981353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Engaging people who use drugs in clinical research: integrating\u00a0facilitated telemedicine for HCV\u00a0into substance use\u00a0treatment"],"prefix":"10.1186","volume":"9","author":[{"given":"Andrew H.","family":"Talal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saliyah J.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian A.","family":"Talal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpan","family":"Dharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ventuneac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Baciewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ponni V.","family":"Perumalswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne S.","family":"Dickerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,2]]},"reference":[{"issue":"3","key":"474_CR1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1377\/hlthaff.2018.05067","volume":"38","author":"LP Forsythe","year":"2019","unstructured":"Forsythe LP, Carman KL, Szydlowski V, Fayish L, Davidson L, Hickam DH, et al. Patient engagement in research: early findings from the Patient-Centered Outcomes Research Institute. Health Aff. 2019;38(3):359\u201367.","journal-title":"Health Aff"},{"issue":"2","key":"474_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/hex.12979","volume":"23","author":"R Hemphill","year":"2020","unstructured":"Hemphill R, Forsythe LP, Heckert AL, Amolegbe A, Maurer M, Carman KL, et al. What motivates patients and caregivers to engage in health research and how engagement affects their lives: qualitative survey findings. Health Expect. 2020;23(2):328\u201336.","journal-title":"Health Expect"},{"key":"474_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40900-020-00227-0","volume":"6","author":"A Heckert","year":"2020","unstructured":"Heckert A, Forsythe LP, Carman KL, Frank L, Hemphill R, Elstad EA, et al. Researchers, patients, and other stakeholders\u2019 perspectives on challenges to and strategies for engagement. Res Involv Engagem. 2020;6:60.","journal-title":"Res Involv Engagem"},{"issue":"12","key":"474_CR4","doi-asserted-by":"publisher","first-page":"897","DOI":"10.7326\/M16-2887","volume":"166","author":"AH Talal","year":"2017","unstructured":"Talal AH, Thomas DL, Reynolds JL, Khalsa JH. Toward optimal control of hepatitis C virus infection in persons with substance use disorders. Ann Intern Med. 2017;166(12):897\u20138.","journal-title":"Ann Intern Med"},{"issue":"1","key":"474_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11469-012-9402-5","volume":"11","author":"V Earnshaw","year":"2013","unstructured":"Earnshaw V, Smith L, Copenhaver M. Drug addiction stigma in the context of methadone maintenance therapy: an investigation into understudied sources of stigma. Int J Ment Health Addict. 2013;11(1):110\u201322.","journal-title":"Int J Ment Health Addict"},{"issue":"12","key":"474_CR6","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.2105\/AJPH.2013.301611","volume":"103","author":"MM Islam","year":"2013","unstructured":"Islam MM. Missed opportunities for hepatitis C testing and other opportunistic health care. Am J Public Health. 2013;103(12):e6.","journal-title":"Am J Public Health"},{"issue":"6","key":"474_CR7","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/cid\/cis1007","volume":"56","author":"RB Dimova","year":"2013","unstructured":"Dimova RB, Zeremski M, Jacobson IM, Hagan H, Des Jarlais DC, Talal AH. Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis. Clin Infect Dis. 2013;56(6):806\u201316.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"474_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1365-2893.2010.01411.x","volume":"19","author":"AD Martinez","year":"2012","unstructured":"Martinez AD, Dimova R, Marks KM, Beeder AB, Zeremski M, Kreek MJ, et al. Integrated internist\u2014addiction medicine\u2014hepatology model for hepatitis C management for individuals on methadone maintenance. J Viral Hepat. 2012;19(1):47\u201354.","journal-title":"J Viral Hepat"},{"issue":"1","key":"474_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jsat.2012.01.010","volume":"44","author":"AH Talal","year":"2013","unstructured":"Talal AH, Dimova RB, Seewald R, Peterson RH, Zeremski M, Perlman DC, et al. Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment. J Subst Abuse Treat. 2013;44(1):115\u20139.","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"474_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/ADM.0000000000000041","volume":"8","author":"M Zeremski","year":"2014","unstructured":"Zeremski M, Dimova RB, Zavala R, Kritz S, Lin M, Smith BD, et al. Hepatitis C virus-related knowledge and willingness to receive treatment among patients on methadone maintenance. J Addict Med. 2014;8(4):249\u201357.","journal-title":"J Addict Med"},{"issue":"2","key":"474_CR11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1377\/hlthaff.2012.1133","volume":"32","author":"KL Carman","year":"2013","unstructured":"Carman KL, Dardess P, Maurer M, Sofaer S, Adams K, Bechtel C, et al. Patient and family engagement: a framework for understanding the elements and developing interventions and policies. Health Aff. 2013;32(2):223\u201331.","journal-title":"Health Aff"},{"key":"474_CR12","doi-asserted-by":"publisher","first-page":"106632","DOI":"10.1016\/j.cct.2021.106632","volume":"112","author":"AH Talal","year":"2022","unstructured":"Talal AH, Markatou M, Sofikitou EM, Brown LS, Perumalswami P, Dinani A, et al. Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: telemedicine for evaluation, adherence and medication for hepatitis C (TEAM-C). Contemp Clin Trials. 2022;112:106632.","journal-title":"Contemp Clin Trials"},{"issue":"2","key":"474_CR13","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/cid\/ciy899","volume":"69","author":"AH Talal","year":"2019","unstructured":"Talal AH, Andrews P, Mcleod A, Chen Y, Sylvester C, Markatou M, et al. Integrated, co-located, telemedicine-based treatment approaches for hepatitis C virus management in opioid use disorder patients on methadone. Clin Infect Dis. 2019;69(2):323\u201331.","journal-title":"Clin Infect Dis"},{"key":"474_CR14","volume-title":"Principles of community engagement","author":"Clinical and Translational Science Awards Consortium","year":"2011","unstructured":"Clinical and Translational Science Awards Consortium. Principles of community engagement. Rockville, MD: US Gov Printing Office; 2011."},{"key":"474_CR15","doi-asserted-by":"publisher","first-page":"108421","DOI":"10.1016\/j.jsat.2021.108421","volume":"127","author":"AH Talal","year":"2021","unstructured":"Talal AH, Jaanim\u00e4gi U, Davis K, Bailey J, Bauer BM, Dharia A, et al. Facilitating engagement of persons with opioid use disorder in treatment for hepatitis C virus infection via telemedicine: Stories of onsite case managers. J Subst Abuse Treat. 2021;127:108421.","journal-title":"J Subst Abuse Treat"},{"key":"474_CR16","doi-asserted-by":"publisher","DOI":"10.4135\/9781529799583","volume-title":"Doing hermeneutic phenomenological research: a practical guide","author":"L Dibley","year":"2020","unstructured":"Dibley L, Dickerson S, Duffy M, Vandermause R. Doing hermeneutic phenomenological research: a practical guide. Thousand Oaks: SAGE; 2020."},{"key":"474_CR17","doi-asserted-by":"publisher","DOI":"10.1089\/tmj.2022.0534","author":"A Ventuneac","year":"2023","unstructured":"Ventuneac A, Dickerson SS, Dharia A, George SJ, Talal AH. Scaling and sustaining facilitated telemedicine to expand treatment access among underserved populations: a qualitative study. Telemed J E Health. 2023. https:\/\/doi.org\/10.1089\/tmj.2022.0534.","journal-title":"Telemed J E Health"},{"key":"474_CR18","volume-title":"Constructing grounded theory","author":"K Charmaz","year":"2014","unstructured":"Charmaz K. Constructing grounded theory. London: Sage; 2014."},{"key":"474_CR19","first-page":"39","volume":"1","author":"JA Smith","year":"2004","unstructured":"Smith JA. Reflecting on the development of interpretative phenomenological analysis and its contribution to qualitative research in psychology. Qual Res Psychol. 2004;1:39\u201354.","journal-title":"Qual Res Psychol"},{"issue":"2","key":"474_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/08870449608400256","volume":"11","author":"JA Smith","year":"1996","unstructured":"Smith JA. Beyond the divide between cognition and discourse: Using interpretative phenomenological analysis in health psychology. Psychol Health. 1996;11(2):261\u201371.","journal-title":"Psychol Health"},{"issue":"1","key":"474_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/14768320500230185","volume":"21","author":"JM Brocki","year":"2006","unstructured":"Brocki JM, Wearden AJ. A critical evaluation of the use of interpretative phenomenological analysis (IPA) in health psychology. Psych Health. 2006;21(1):87\u2013108.","journal-title":"Psych Health"},{"issue":"2","key":"474_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1365-2648.2006.03898.x","volume":"55","author":"L De Witt","year":"2006","unstructured":"de Witt L, Ploeg J. Critical appraisal of rigour in interpretive phenomenological nursing research. J Adv Nurs. 2006;55(2):215\u201329.","journal-title":"J Adv Nurs"},{"issue":"9","key":"474_CR23","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1089\/tmj.2018.0161","volume":"25","author":"AH Talal","year":"2019","unstructured":"Talal AH, McLeod A, Andrews P, Nieves-McGrath H, Chen Y, Reynolds A, et al. Patient reaction to telemedicine for clinical management of hepatitis C virus integrated into an opioid treatment program. Telemed J E Health. 2019;25(9):791\u2013801.","journal-title":"Telemed J E Health"},{"issue":"2","key":"474_CR24","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/ADM.0000000000000196","volume":"10","author":"M Zeremski","year":"2016","unstructured":"Zeremski M, Zavala R, Dimova RB, Chen Y, Kritz S, Sylvester C, et al. Improvements in HCV-related knowledge among substance users on opioid agonist therapy after an educational intervention. J Addict Med. 2016;10(2):104\u20139.","journal-title":"J Addict Med"},{"key":"474_CR25","unstructured":"Person-Centered Care Guidance for OASAS Certified Programs. https:\/\/oasas.ny.gov\/system\/files\/documents\/2020\/01\/oasasperson-centeredcareguidance.pdf"},{"issue":"5","key":"474_CR26","doi-asserted-by":"publisher","first-page":"972","DOI":"10.4254\/wjh.v14.i5.972","volume":"14","author":"AH Talal","year":"2022","unstructured":"Talal AH, Ding YX, Markatou M. Innovations in education: a prospective study of storytelling narratives to enhance hepatitis C virus knowledge among substance users. World J Hepatol. 2022;14(5):972\u201383.","journal-title":"World J Hepatol"},{"issue":"4","key":"474_CR27","first-page":"20","volume":"27","author":"A Reynolds","year":"2015","unstructured":"Reynolds A. The value of an HCV cure: Curing HCV benefits the individual\u2014and society. Posit Aware. 2015;27(4):20\u20133.","journal-title":"Posit Aware"},{"issue":"2","key":"474_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/10826084.2017.1400068","volume":"53","author":"JS Woods","year":"2018","unstructured":"Woods JS, Joseph H. From narcotic to normalizer: the misperception of methadone treatment and the persistence of prejudice and bias. Subst Use Misuse. 2018;53(2):323\u20139.","journal-title":"Subst Use Misuse"},{"issue":"3","key":"474_CR29","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1089\/tmj.2022.0189","volume":"29","author":"AH Talal","year":"2023","unstructured":"Talal AH, Sofikitou EM, Wang K, Dickerson S, Jaanimagi U, Markatou M. High satisfaction with patient-centered telemedicine for hepatitis C virus delivered to substance users: a mixed-methods study. Telemed J E Health. 2023;29(3):395\u2013407.","journal-title":"Telemed J E Health"},{"issue":"1","key":"474_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.drugpo.2007.02.003","volume":"19","author":"CE Munoz-Plaza","year":"2008","unstructured":"Munoz-Plaza CE, Strauss S, Astone-Twerell J, Jarlais DD, Gwadz M, Hagan H, et al. Exploring drug users\u2019 attitudes and decisions regarding hepatitis C (HCV) treatment in the US. Int J Drug Policy. 2008;19(1):71\u20138.","journal-title":"Int J Drug Policy"},{"key":"474_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev.publhealth.19.1.173","volume":"19","author":"BA Israel","year":"1998","unstructured":"Israel BA, Schulz AJ, Parker EA, Becker AB. Review of community-based research: assessing partnership approaches to improve public health. Annu Rev Public Health. 1998;19:173\u2013202.","journal-title":"Annu Rev Public Health"},{"key":"474_CR32","volume-title":"Improving representation in clinical trials and research: building research equity for women and underrepresented groups","author":"National Academies of Sciences, Engineering, and Medicine","year":"2022","unstructured":"National Academies of Sciences, Engineering, and Medicine. Improving representation in clinical trials and research: building research equity for women and underrepresented groups. Washington: The National Academies Press; 2022."},{"key":"474_CR33","doi-asserted-by":"crossref","unstructured":"Wilkins CH. Effective engagement requires trust and being trustworthy. Med Care. 2018;56 Suppl 10 Suppl 1:S6-S8.","DOI":"10.1097\/MLR.0000000000000953"},{"issue":"10","key":"474_CR34","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1177\/0193945920983332","volume":"43","author":"HM Young","year":"2021","unstructured":"Young HM, Miyamoto S, Henderson S, Dharmar M, Hitchcock M, Fazio S, et al. Meaningful engagement of patient advisors in research: towards mutually beneficial relationships. West J Nurs Res. 2021;43(10):905\u201314.","journal-title":"West J Nurs Res"},{"issue":"2 Suppl 1","key":"474_CR35","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/ADT.0000000000000104","volume":"16","author":"SA Gonzalez","year":"2017","unstructured":"Gonzalez SA, Fierer DS, Talal AH. Medical and behavioral approaches to engage people who inject drugs into care for hepatitis C virus infection. Addict Disord Their Treat. 2017;16(2 Suppl 1):S1\u201323.","journal-title":"Addict Disord Their Treat"},{"key":"474_CR36","volume-title":"Beyond methadone: Improving health and empowering patients in opioid treatment programs","author":"A Kasdan","year":"2011","unstructured":"Kasdan A, Marotta P, Hamburg A. Beyond methadone: Improving health and empowering patients in opioid treatment programs. New York, NY: Community Development Project of the Urban Justice Center; 2011."},{"key":"474_CR37","unstructured":"New York State Department of Health. Hepatitis C Telehealth Toolkit. Albany, NY: New York State Department of Health; 2023. https:\/\/ceitraining.org\/documents\/HCV_Telehealth%20Toolkit_FINAL2023pdf. Accessed 12 Feb 2023."},{"key":"474_CR38","unstructured":"McDonald J. New York State Department of Health issues commissioner determination for the use of telemedicine to ensure continued access to life saving medication for New Yorkers struggling with mental health and opioid use disorder. Albany: New York State Department of Health; 2023. https:\/\/www.health.ny.gov\/professionals\/narcotic\/docs\/2023-01-31_telemedicine_initial_exampdf. Accessed 5 Feb 2023."}],"container-title":["Research Involvement and Engagement"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40900-023-00474-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40900-023-00474-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40900-023-00474-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T13:06:00Z","timestamp":1690981560000},"score":1,"resource":{"primary":{"URL":"https:\/\/researchinvolvement.biomedcentral.com\/articles\/10.1186\/s40900-023-00474-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,2]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["474"],"URL":"https:\/\/doi.org\/10.1186\/s40900-023-00474-x","relation":{},"ISSN":["2056-7529"],"issn-type":[{"value":"2056-7529","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,2]]},"assertion":[{"value":"28 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the University at Buffalo Institutional Review Board (IRB) and the ethics committees at each of the participating sites.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate."}},{"value":"All authors have reviewed the final manuscript and grant permission for submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AHT receives grant support from PCORI, NIH, Kaleida Health Foundation, US FDA and he has received honoraria from Mt. Sinai Medical Center, Chronic Liver Disease Foundation, Downstate Medical Center, National AIDS Treatment Advocacy Program, and National Association of State and Territorial AIDS Directors. SJ, AD, AV, GB, PV, and SSD are supported by PCORI. AD and SSD were supported by the Kaleida Health Foundation. GB has been supported by a grant from HRSA and she has received an honorarium from the National Council on Alcoholism and Drug Dependence. LAT has nothing to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}